Zentalis Pharmaceuticals lands $85 mln Series C
New York and San Diego-based Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised $85 million in Series C financing.
New York and San Diego-based Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised $85 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination